Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma
The Laryngoscope May 17, 2019
Bauer E, et al. - Researchers analyzed a retrospective cohort of cases diagnosed with human papillomavirus–positive oropharyngeal squamous cell carcinoma (HPV-positive OPSCC) from 2010 to 2015 in the National Cancer Database in order to comprehensively investigate extranodal extension (ENE) as a prognosticator. All OPSCC HPV-positive cases with appropriate International Classification of Diseases-0-3 codes that received surgery with a neck dissection were included. Observations revealed the highest 5-year survival for cases that were ENE-negative and the lowest 5-year survival for ENE-positive cases. They noted an increased risk of death in correlation to nodal (N) category 1, ENE-positive status compared with N1, ENE-negative status. Compared to node-positive/ENE-negative status, both microscopic and macroscopic ENE were correlated to worse outcomes. To develop and discuss treatment plans for HPV-positive OPSCC, the American Joint Committee on Cancer 8th edition staging system affords a much-improved framework. They recommend carefully considering the importance of ENE in these patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries